Thorac Cardiovasc Surg 2020; 68(S 01): S1-S72
DOI: 10.1055/s-0040-1705463
Oral Presentations
Tuesday, March 3rd, 2020
Aortic Disease
Georg Thieme Verlag KG Stuttgart · New York

Hans Georg Borst Preis: Midterm Results with the Frozen-Elephant Trunk Technique (E-vita Open) in Thoracic Aortic Disease: A Single-Center Experience in 199 Patients

M. Liebrich
1   Stuttgart, Germany
,
S. Schlereth
1   Stuttgart, Germany
,
D. Roser
1   Stuttgart, Germany
,
H. Strauss
1   Stuttgart, Germany
,
D. R. Merk
1   Stuttgart, Germany
,
T. Hupp
1   Stuttgart, Germany
,
N. Doll
1   Stuttgart, Germany
,
V. Voth
1   Stuttgart, Germany
,
W. Hemmer
1   Stuttgart, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
13. Februar 2020 (online)

 

    Objectives: The frozen-elephant trunk (FET) technique is performed to achieve one-stage treatment of the proximal and distal thoracic aorta in different pathologies: acute (AAD) or chronic (CAD) type I aortic dissection and degenerative thoracic aortic aneurysms (TAA). We demonstrate our midterm results up to 10 years.

    Methods: Between January 2009 and January 2019, a total of 199 patients (mean age: 64 ± 21 years) were treated with the FET for AAD (n = 88), CAD (n = 50), TAA (n = 61). Pre-/intra- and postoperative data and follow-up results including aortic remodeling and reintervention rates are presented.

    Results: Overall 30-day mortality was 15%–20% for AAD, 14% for CAD, and 7% in TAA. Univariable analysis identified peripheral arterial disease, instable hemodynamics, aortic x-clamp time, and diameter size of the proximal descending aorta as risk factors for 30-day mortality. After 5 years, estimated survival was 55% in AAD, 59% in CAD, and 78% in TAA. Freedom from endovascular intervention downstream at 5 years was 72% in AAD, 74% in CAD, and 51% in TAA patients. Freedom from thoraco-abdominal surgery was 97, 92, and 93%, respectively.

    Conclusion: The FET provides durable midterm performance in different pathologies of the thoracic aorta in terms of avoiding proximal endoleakage/graft failure during follow-up and enabling a robust docking or landing zone for either open surgery or thoracic endovascular repair.


    #

    Die Autoren geben an, dass kein Interessenkonflikt besteht.